Stéphane Epelbaum

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Venues

Alzheimer's research & therapy

AJOB neuroscience

Neurology

Theoretical medicine and bioethics

Hôpitaux Universitaires Pitié Salpêtrière – Charles Foix

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hôpitaux Universitaires Pitié Salpêtrière – Charles Foix Oct 01 2008

France

MD, PhD :: neurology

Publications

Timothy Daly, Stéphane Epelbaum
The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease. AJOB neuroscience (2022)
Dario Saracino, Sophie Ferrieux, Marie Noguès-Lassiaille, Marion Houot, Aurélie Funkiewiez, Leila Sellami, Vincent Deramecourt, Florence Pasquier, Philippe Couratier, Jérémie Pariente, Amandine Géraudie, Stéphane Epelbaum, David Wallon, Didier Hannequin, Olivier Martinaud, Fabienne Clot, Agnès Camuzat, Simona Bottani, Daisy Rinaldi, Sophie Auriacombe, Marie Sarazin, Mira Didic, Claire Boutoleau-Bretonnière, Christel Thauvin-Robinet, Julien Lagarde, Carole Roué-Jagot, François Sellal, Audrey Gabelle, Frédérique Etcharry-Bouyx, Alexandre Morin, Cinzia Coppola, Richard Levy, Bruno Dubois, Alexis Brice, Olivier Colliot, Maria Luisa Gorno-Tempini, Marc Teichmann, Raffaella Migliaccio, Isabelle Le Ber, null null
Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Nonamyloid Logopenic Variant. Neurology 97 (1) (2021)
Timothy Daly, Ignacio Mastroleo, David H Gorski, Stéphane Epelbaum
The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols. Theoretical medicine and bioethics 41 (5-6) (2021)
Federica Cacciamani, Luisa Sambati, Marion Houot, Marie-Odile Habert, Bruno Dubois, Stéphane Epelbaum, null null
Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD. Alzheimer's research & therapy 12 (1) (2020)
Stéphane Epelbaum, Claire Paquet, Jacques Hugon, Julien Dumurgier, David Wallon, Didier Hannequin, Thérèse Jonveaux, Annick Besozzi, Stéphane Pouponneau, Caroline Hommet, Frederic Blanc, Laetitia Berly, Adrien Julian, Marc Paccalin, Florence Pasquier, Julie Bellet, Claire Boutoleau-Bretonniere, Thiphaine Charriau, Olivier Rouaud, Olivier Madec, Aurélie Mouton, Renaud David, Samir Bekadar, Roxane Fabre, Emmanuelle Liegey, Walter Deberdt, Philippe Robert, Bruno Dubois
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years. BMJ open 9 (6) (2019)

Stéphane Epelbaum.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stéphane Epelbaum